PTAB statistics

PTAB Trial Statistics as of December 18, 2014

As of December 18, 2014, USPTO records show 2,496 AIA trial petitions filed since September 16, 2012 (2,216 IPR, 271 CBM, 3 PGR, 6 derivation). The Board had instituted trial on 1,104 petitions and denied 526 (67.7% instituted) and had issued 235 final written decisions. In fiscal year 2015 to that date, 415 petitions were filed.

Key Facts

As of
December 18, 2014
Fiscal year
FY2015
Petitions filed (cumulative)
2,496
Institution rate (cumulative)
67.7%
Petitions filed (FY2015 to date)
415
Data retrieved
October 31, 2026
On this page
  1. Cumulative Figures as of December 18, 2014
  2. Fiscal Year 2015 to Date
  3. Change Since December 4, 2014
  4. Trial Types Covered
  5. How These Figures Were Compiled
  6. Related Statistics

This page gives Patent Trial and Appeal Board trial figures as of December 18, 2014, which falls in fiscal year 2015 (October 1, 2014 to September 30, 2015). The cumulative figures run from September 16, 2012, when AIA trials began. The full year is covered on the FY2015 statistics page.

Cumulative Figures as of December 18, 2014

Events from September 16, 2012 to December 18, 2014, by trial type:

MeasureIPRPGRCBMDERTotal
Petitions filed2,216327162,496
Institution decisions: instituted981012301,104
Institution decisions: denied4611613526
Institution rate (by petition)68.0%0.0%66.8%0.0%67.7%
Final written decisions2090260235
Terminations without a final written decisionCount
Settlements209
Adverse judgment0
Dismissed0
Other terminations8

Fiscal Year 2015 to Date

Events from October 1, 2014 to December 18, 2014:

MeasureIPRPGRCBMDERTotal
Petitions filed3751381415
Institution decisions: instituted2420160258
Institution decisions: denied108150114
Institution rate (by petition)69.1%0.0%76.2%—69.4%
Final written decisions5909068
Terminations without a final written decisionCount
Settlements65
Adverse judgment0
Dismissed0
Other terminations0

Change Since December 4, 2014

Between the previous dated page (December 4, 2014) and December 18, 2014, 82 petitions were filed, 60 trials were instituted, 34 petitions were denied institution and 18 final written decisions issued. The cumulative institution rate moved from 68.0% to 67.7%.

Trial Types Covered

2,216 of the 2,496 petitions (88.8%) were for inter partes review, which challenges patent claims on prior-art grounds under 35 U.S.C. chapter 31. The remainder were for covered business method review (271), post-grant review under chapter 32 (3) and derivation proceedings (6). Institution standards differ by proceeding; see the threshold standards.

How These Figures Were Compiled

The figures are counted from USPTO Open Data Portal records retrieved on October 31, 2026, keeping only events dated on or before December 18, 2014: a petition by its filing date, an institution decision by its decision date, and a final written decision or termination by its date. They are a reconstruction from the current records, not the USPTO’s report of that date, and may differ from statistics the USPTO published at the time. Final written decision outcomes are not reported because the records state them for too few decisions. The methodology gives the counting rules in full.

Frequently Asked Questions

How many AIA trial petitions had been filed as of December 18, 2014?

USPTO records show 2,496 petitions filed from September 16, 2012 to December 18, 2014: 2,216 IPR, 271 CBM, 3 PGR and 6 derivation.

What was the PTAB institution rate as of December 18, 2014?

Cumulatively, 67.7% by petition: 1,104 instituted and 526 denied. In FY2015 to that date the rate was 69.4%.

Primary Sources

  1. USPTO Open Data Portal (PTAB trial proceedings and decisions data)
  2. USPTO Patent Trial and Appeal Board statistics
  3. 35 U.S.C. chapter 31 (inter partes review)
  4. 35 U.S.C. chapter 32 (post-grant review)
  5. 37 C.F.R. Part 42 (trial practice before the PTAB)

Educational information; not legal advice. Statutes, rules and USPTO practice change. Confirm against the primary sources and consult a registered patent practitioner before acting. Disclaimer.